Clinical Trials Directory

Trials / Recruiting

RecruitingNCT02757859

High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery

The WASH Trial: A Randomized Trial of Abdominal Lavage Using Distilled Water or Saline at High Volumes for Resected Pancreatic Cancer

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
845 (estimated)
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This randomized clinical trial studies how well high volume washing of the abdomen works in increasing survival after surgery in patients with pancreatic cancer that can be removed by surgery. High volume washings may remove free floating cancers present after surgery and help prolong survival in patients with pancreatic cancer.

Detailed description

PRIMARY OBJECTIVES: I. Overall survival (OS) (18 to 27 months after resection). SECONDARY OBJECTIVES: I. Disease free survival (DFS). II. Complication rate. III. Site of first-recurrence (by site, and distant vs. local). IV. Clearance of malignant cells pre vs. post-lavage. OUTLINE: Patients are randomized to 1 of 3 arms. ARM I (EIPL-S): Patients undergo pancreaticoduodenectomy, distal pancreatectomy, or total pancreatectomy. Immediately after removal of tumor, patients receive extensive intraoperative peritoneal saline (EIPL-S) lavage 10 times over 15 minutes. ARM II (EIPL-D): Patients undergo pancreaticoduodenectomy, distal pancreatectomy, or total pancreatectomy. Immediately after removal of tumor, patients receive extensive intraoperative peritoneal distilled water (EIPL-D) lavage 10 times over 15 minutes. ARM III (NO LAVAGE): Patients undergo pancreaticoduodenectomy, distal pancreatectomy, or total pancreatectomy with no extensive lavage after removal of tumor. After completion of study treatment, patients are followed up every 3 months.

Conditions

Interventions

TypeNameDescription
PROCEDUREPancreatectomyUndergo pancreaticoduodenectomy, distal pancreatectomy, or total pancreatectomy
OTHERLavageReceive EIPL-S
PROCEDUREPancreatectomyUndergo pancreaticoduodenectomy, distal pancreatectomy, or total pancreatectomy
OTHERLavageReceive EIPL-D
PROCEDUREPancreatectomyUndergo pancreaticoduodenectomy, distal pancreatectomy, or total pancreatectomy

Timeline

Start date
2016-04-27
Primary completion
2026-04-27
Completion
2026-04-27
First posted
2016-05-02
Last updated
2025-05-20

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02757859. Inclusion in this directory is not an endorsement.